Dietary Supplement
pinaverium bromide
pinaverium bromide is a dietary supplement with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
50%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (50.0%)
N/A2 (50.0%)
Trials by Status
unknown250%
completed125%
enrolling_by_invitation125%
Recent Activity
0 active trials
Showing 4 of 4
enrolling_by_invitationnot_applicable
Pinaverium Bromide Preventing Post Extracorporeal Shock Wave Lithotripsy Pancreatitis and Painful (PBPEP)
NCT06936800
unknownnot_applicable
Impact of Pinaverium Bromide on Bile Duct and Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography
NCT02882451
unknownphase_4
Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction
NCT02833103
completedphase_4
Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)
NCT02173964
Clinical Trials (4)
Showing 4 of 4 trials
NCT06936800Not Applicable
Pinaverium Bromide Preventing Post Extracorporeal Shock Wave Lithotripsy Pancreatitis and Painful (PBPEP)
NCT02882451Not Applicable
Impact of Pinaverium Bromide on Bile Duct and Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography
NCT02833103Phase 4
Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction
NCT02173964Phase 4
Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4